- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT01704885
A Cognitive- Behavioral Play Intervention for Siblings of Children Diagnosed With Cancer
A Cognitive- Behavioral Play Intervention for Siblings of Children Diagnosed With Cancer: A Pilot Study
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
Aim 1: Assess baseline adjustment, coping, pretend play, parenting stress, and family interactions.
- Hypothesis 1a: Children with siblings diagnosed with cancer will have lower levels of adjustment, coping skills, and pretend play compared to previous sample norms.
- Hypothesis 1b: The child's adjustment will be mediated by factors related to their involvement in the sibling's medical care, such as parent's level of communication regarding their sibling's illness, frequent isolation from the family and other social support, time since their sibling's diagnosis, and parenting stress. -Hypothesis 1c: Parents of children diagnosed with cancer will report higher levels of parenting stress compared to previous sample norms.
Aim 2: Assess outcome of three play intervention sessions focusing on increasing coping and adjustment.
- Hypothesis 2a: Compared to the active control, children in the play intervention group will have increased coping skills after intervention.
- Hypothesis 2b: Compared to the active control, children in the play intervention group will have better psychological adjustment following intervention.
- Hypothesis 2c: Parents of children in the play intervention group will report decreased parenting stress following the intervention.
Once parents consent to participate and their child provides assent, they and their child will complete the baseline questionnaires and measures. Immediately following completion of the baseline measures, the child will be randomly assigned to either the play intervention or active control group.Children will also be asked to rate their mood at the beginning of each play session. The outcome parent and child questionnaires will be administered again at a session approximately one week after the third play session, for a total of four play sessions each spaced approximately one week apart. Children will also be asked to rate their satisfaction with the treatment at the outcome session (e.g., "How much did you like being a part of this study?").
Tipo di studio
Iscrizione (Effettivo)
Fase
- Prima fase 1
Contatti e Sedi
Luoghi di studio
-
-
Ohio
-
Cleveland, Ohio, Stati Uniti, 44106
- Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Families who have had children diagnosed with any type of cancer in the past year.
- At least one sibling between the ages of 4 and 10 years old
- Patients will be targeted 1-2 months after diagnosis, but could be included in the study up to 12 months following diagnosis.
Exclusion Criteria:
-
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Terapia di supporto
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Separare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Comparatore fittizio: Active Control Group
Children in the active control group will play with puzzles, a building toy, or color.
The play facilitator will praise the child and interact at a similar rate to control for interaction with a caring adult.
|
Altri nomi:
|
|
Sperimentale: Play Intervention
children in the play intervention group will be given 3 story stems that they are asked to play out with the goal of helping the main character "feel better" (see session scripts).
The play facilitator will play with the child, modeling and praising use of positive coping skills.
In the first session the play facilitator will focus on positive self-statements, in the second session the play facilitator will focus on problem-solving, and a combination of these two approaches will be used in the final session.
The child will be allowed to make up a story about whatever they want before ending each session.
|
Altri nomi:
Altri nomi:
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Number of children with increase in coping skills after intervention
Lasso di tempo: 4 weeks
|
Compared to the active control, children in the play intervention group will have increased coping skills after intervention.
|
4 weeks
|
|
Number of children with better psychological adjustment following intervention
Lasso di tempo: 4 weeks
|
Compared to the active control, children in the play intervention group will have better psychological adjustment following intervention.
|
4 weeks
|
|
Number of parents with decreased parenting stress following intervention
Lasso di tempo: 4 weeks
|
Parents of children in the play intervention group will report decreased parenting stress following the intervention.
|
4 weeks
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Karla Fehr, M.A., Case Western Reserve University
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- CASE4Z11
- CC00130 (Altro identificatore: University Hospitals Cancer IRB)
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .